Douglas L Braunstein
CIK 1495110 · See Remarks · last filed 2026-08-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TALKW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
570 LEXINGTON AVENUE, 35TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Talkspace, Inc. (TALK) Delisted | Director | 0 | $5.25 | $0 | $0 | 1 | 2026-08-17 |
| Talkspace, Inc. (TALKW) Delisted | Director | 3,088,020 | $0.00 | $618 | $53.02M | 15 | 2026-06-03 |
| CANTALOUPE, INC. (CTLP) Delisted | 10%+ Owner | 12,188,827 | $11.20 | $136.51M | $1.95M | 2 | 2022-05-25 |
| Hudson Executive Investment Corp. III (HIIIU) Delisted | President, Chairman | — | $10.08 | — | $0 | 1 | 2021-04-14 |
| CANTALOUPE, INC. (USAT) Delisted | 10%+ Owner | 11,036,174 | $12.16 | $134.20M | $0 | 2 | 2020-07-02 |
| Cardtronics plc (CATM) Delisted | Director | 8,135,021 | $39.01 | $317.35M | $0 | 1 | 2020-04-02 |
| Corindus Vascular Robotics, Inc. (CVRS) Delisted | Director | 14,341,764 | — | — | $4.00M | 11 | 2019-10-09 |
| CANTALOUPE, INC. (USATP) Delisted | 10%+ Owner | 10,140,172 | — | — | $24.74M | 1 | 2019-09-26 |
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 810,365 | $2.14 | $1.73M | -$8.06M | 7 | 2019-09-19 |
| JPM | Chief Financial Officer | 603,836 | $335.04 | $202.31M | $0 | 5 | 2013-01-04 |
Recent Filings · Page 4 of 5
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-14 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Buy (P) | +2,899,391 | $4.00M | EDGAR |
| 2019-01-25 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-10 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +5,357 | $6.0K | EDGAR |
| 2018-10-09 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +3,200 | $4.0K | EDGAR |
| 2018-07-11 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +4,273 | $5.0K | EDGAR |
| 2018-06-04 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +53,326 | $40.0K | EDGAR |
| 2018-04-10 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +653 | $888 | EDGAR |
| 2018-03-20 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +6,780 | $0 | EDGAR |
| 2018-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-11 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Buy (P) | +20,400 | $1.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.